Florian Rieder

Active 2001–2025

141
Papers
19,602
Citations
62
h-index
122
i10-index

Citations

Citations per year for Florian Rieder1978: 1 citations1994: 3 citations2000: 2 citations2001: 5 citations2002: 9 citations2003: 9 citations2004: 12 citations2005: 5 citations2006: 12 citations2007: 12 citations2008: 36 citations2009: 43 citations2010: 39 citations2011: 58 citations2012: 61 citations2013: 59 citations2014: 83 citations2015: 82 citations2016: 72 citations2017: 90 citations2018: 169 citations2019: 598 citations2020: 808 citations2021: 866 citations2022: 895 citations2023: 769 citations2024: 1,585 citations2025: 791 citations2026: 21 citations1979–1993: no citations, so these years are not shown1995–1999: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,402 citing papers, 16.4% of this breakdownChina: 1,295 citing papers, 15.1% of this breakdownItaly: 661 citing papers, 7.7% of this breakdownUnited Kingdom: 524 citing papers, 6.1% of this breakdownGermany: 465 citing papers, 5.4% of this breakdownCanada: 358 citing papers, 4.2% of this breakdownFrance: 329 citing papers, 3.8% of this breakdownNetherlands: 301 citing papers, 3.5% of this breakdownSpain: 280 citing papers, 3.3% of this breakdownJapan: 248 citing papers, 2.9% of this breakdownBelgium: 198 citing papers, 2.3% of this breakdownSwitzerland: 192 citing papers, 2.3% of this breakdown
0%16.4%Other 27%

Fields

  • Biochemistry, Genetics and Molecular Biology51.3%
  • Medicine36.9%
  • Immunology and Microbiology6.1%
  • Neuroscience1.3%
  • Engineering0.7%
  • Agricultural and Biological Sciences0.7%
  • Other3%

Topics

  • Inflammatory Bowel Disease15.5%
  • Microscopic Colitis5.1%
  • Gut microbiota and health2.7%
  • Autoimmune and Inflammatory Disorders2.4%
  • Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis1.8%
  • IL-33, ST2, and ILC Pathways1.7%
  • Other70.8%

Coauthors

All papers

Open in search
  1. Fibrosis: from mechanisms to medicines

    Authors: , , - Nature 2020 cited by 1,870

  2. ECCO-ESGAR Guideline for Diagnostic Assessment in IBD Part 1: Initial diagnosis, monitoring of known IBD, detection of complications

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Journal of Crohn s and Colitis 2018 cited by 1,822

  3. Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 1: Definitions, Diagnosis, Extra-intestinal Manifestations, Pregnancy, Cancer Surveillance, Surgery, and Ileo-anal Pouch Disorders

    Authors: , , , , , , , , , , , , , , , , - Journal of Crohn s and Colitis 2017 cited by 1,884

  4. 3rd European Evidence-based Consensus on the Diagnosis and Management of Crohn’s Disease 2016: Part 1: Diagnosis and Medical Management

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - Journal of Crohn s and Colitis 2016 cited by 2,071

  5. IL-12 and IL-23 pathway inhibition in inflammatory bowel disease

    Authors: , , , , , , , , , , , , , , , , , , , , , - Nature Reviews Gastroenterology & Hepatology 2023 cited by 231

  6. Mechanisms, Management, and Treatment of Fibrosis in Patients With Inflammatory Bowel Diseases

    Authors: , , - Gastroenterology 2016 cited by 512

  7. The Origin and Contribution of Cancer-Associated Fibroblasts in Colorectal Carcinogenesis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Anil K. Rustgi, Siddhartha Mukherjee, Masahide Takahashi, Timothy C. Wang, Atsushi Enomoto, Susan L. Woods, Daniel L. Worthley - Gastroenterology 2021 cited by 207

  8. ECCO-ESGAR Guideline for Diagnostic Assessment in IBD Part 2: IBD scores and general principles and technical aspects

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Journal of Crohn s and Colitis 2018 cited by 453

  9. Fibrosis in IBD: from pathogenesis to therapeutic targets

    Authors: , , , , - Gut 2024 cited by 156

  10. Assessment of Crohn’s disease-associated small bowel strictures and fibrosis on cross-sectional imaging: a systematic review

    Authors: , , , , , , , , , , , , - Gut 2019 cited by 303

  11. An expert consensus to standardise definitions, diagnosis and treatment targets for anti‐fibrotic stricture therapies in Crohn's disease

    Authors: , , , , , , , , , , , , , , , , , , , , - Alimentary Pharmacology & Therapeutics 2018 cited by 258

  12. Crohn's disease complicated by strictures: a systematic review

    Authors: , , , - Gut 2013 cited by 505

  13. Fibrosis in ulcerative colitis is directly linked to severity and chronicity of mucosal inflammation

    Authors: , , , , , , , , , , , - Alimentary Pharmacology & Therapeutics 2018 cited by 205

  14. Stricturing Crohn’s Disease Single-Cell RNA Sequencing Reveals Fibroblast Heterogeneity and Intercellular Interactions

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Stefan D. Holubar, Scott R. Steele, Claudio Fiocchi, Andrei I. Ivanov, Kellie M. Kravarik, Florian Rieder - Gastroenterology 2023 cited by 96

  15. The Mesenteric Fat and Intestinal Muscle Interface: Creeping Fat Influencing Stricture Formation in Crohn’s Disease

    Authors: , , , , , , , - Inflammatory Bowel Diseases 2018 cited by 206

  16. The Pathogenesis of Extraintestinal Manifestations: Implications for IBD Research, Diagnosis, and Therapy

    Authors: , , , , , , , , , , , , , , , , , , , , - Journal of Crohn s and Colitis 2018 cited by 217

  17. Inflammation-Induced Endothelial-to-Mesenchymal Transition

    Authors: , , , , , , , , - American Journal Of Pathology 2011 cited by 314

  18. Development and Validation of a Novel Computed-Tomography Enterography Radiomic Approach for Characterization of Intestinal Fibrosis in Crohn’s Disease

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - Gastroenterology 2021 cited by 117

  19. Novel mechanisms and clinical trial endpoints in intestinal fibrosis*

    Authors: , , , , , - Immunological Reviews 2021 cited by 111

  20. IL-36 in chronic inflammation and fibrosis — bridging the gap?

    Authors: , , , , , , , - Journal of Clinical Investigation 2021 cited by 111

  21. Intestinal fibrosis in IBD—a dynamic, multifactorial process

    Authors: , - Nature Reviews Gastroenterology & Hepatology 2009 cited by 339

  22. Understanding disruption of the gut barrier during inflammation: Should we abandon traditional epithelial cell lines and switch to intestinal organoids?

    Authors: , , , , - Frontiers in Immunology 2023 cited by 67

  23. Fibrostenotic strictures in Crohn’s disease

    Authors: , , - Intestinal Research 2020 cited by 102

  24. Challenges in the Pathophysiology, Diagnosis, and Management of Intestinal Fibrosis in Inflammatory Bowel Disease

    Authors: , , , , , , , , , , , , , , , , , , , , - Gastroenterology 2019 cited by 95